Cross Kingdom Functional Conservation Core Universally
Conserved Threonylcarbamoyladenosine tRNA Synthesis Enzymes
Patrick C. Thiaville b,c,d Basma El Yacoubi,d Ludovic Perrochia,c Arnaud Hecker,e Magali Prigent,c Jennifer J. Thiaville,d
Patrick Forterre,c Olivier Namy,c Tamara Basta,c ValÃ©rie CrÃ©cy-Lagardb,d
Genetics Genomics Graduate Program, University Florida, Gainesville, Florida, USAa; University Florida Genetics Institute, Gainesville, Florida, USAb; Institut GÃ©nÃ©tique et Microbiologie, UniversitÃ© Paris-Sud, Orsay, Francec; Department Microbiology Cell Science, University Florida, Gainesville, Florida, USAd;
UniversitÃ© Lorraine, UMR 1136 INRA/UniversitÃ© Lorraine Interactions Arbres-Microorganismes, Labex ARBRE, FR EFABA, FacultÃ© des Sciences, Vandoeuvre, Francee

Threonylcarbamoyladenosine (t6A) universal modification located anticodon stem-loop tRNAs. yeast, cytoplasmic mitochondrial tRNAs modified. cytoplasmic t6A synthesis pathway elucidated requires
Sua5p, Kae1p, KEOPS complex proteins. Recent vitro work suggested mitochondrial t6A ma-
chinery Saccharomyces cerevisiae composed proteins, Sua5p Qri7p, member Kae1p/TsaD family
(L. C. K. Wan et al., Nucleic Acids Res. 41:6332â€“ 6346, 2013, http://dx.doi.org/10.1093/nar/gkt322). Sua5p catalyzes step
leading threonyl-carbamoyl-AMP intermediate (TC-AMP), Qri7 transfers threonyl-carbamoyl moiety TC-
AMP tRNA form t6A. Qri7p localizes mitochondria, Sua5p reported cytoplasmic. Sua5p targeted cytoplasm mitochondria use alternative start sites. import Sua5p mi-
tochondria required organelle functional, TC-AMP intermediate produced Sua5p cytoplasm transported mitochondria sufficient amounts. minimal t6A pathway characterized vitro  time, vivo heterologous complementation studies Escherichia coli. data revealed potential TC-AMP chan-
neling t6A pathway, coexpression Qri7p Sua5p required complement essentiality E. coli tsaD
mutant. results firmly established Qri7p Sua5p constitute mitochondrial pathway biosynthesis t6A bring additional advancement understanding reaction mechanism.


    s central adaptors responsible accurate decoding      mRNA, tRNA molecules critical cell survival. order ensure accuracy decoding, tRNAs harbor posttranscrip-
                                                                                         verts carbon dioxide  bicarbonate), L-threonine, ATP                                                                                          L-threonylcarbamoyl-AMP (TC-AMP) intermediate (16).
                                                                                         TC-AMP converted t6A YdiCBs (TsaBEc), YdiBBs
tional modifications mainly anticodon stem loop (ASL) (1).                        (TsaEEc), YdiEBs (TsaDEc) presence tRNA (16). N6-threonyl-carbamoyl-adenosine (t6A), modification aden-                           work extended TC-AMP produced TsaC osine located position 37 anticodon (t6A37),                         Sua5p eukaryotic archaeal origin converted highly conserved tRNA modification present domains life.                       t6A-modified tRNA E. coli TsaDEB enzymes, S. cerevi- modification present nearly ANN-decoding tRNAs                            siae KEOPS complex, Pyrococcus abyssi KEOPS complex
 exception tRNAiMet bacteria) (2). Like modifica-                        (11). short, enzyme family organisms, TsaC/
tions position 37, m1G, i6A, ms2i6A modifica-                        Sua5, catalyzes formation TC-AMP. step tions (3, 4), t6A important translation fidelity                       transferring TC tRNA, bacteria require TsaBDE, archaea
stabilizes ASL structure enhances codon-anticodon inter-                         eukaryotes use KEOPS complex. Interestingly, action (5).                                                                              TsaBDE KEOPS functional analogues, TsaD/
    enzymatic synthesis t6A studied vitro                      Kae1 proteins shared systems (Fig. 1), sug-
vivo 40 years (2, 6â€“9), synthesis pathways                         gesting protein ancestral t6A synthesis core recently elucidated, revealing core set enzymes                      present universal common ancestor (LUCA) (17). kingdom-specific variations (Fig. 1) (10, 11). universal                         hypothesis strengthened demonstration S.
protein families involved biosynthesis t6A: TsaC/Sua5                      cerevisiae minimal comprised just Sua5p Kae1/ Kae1/Qri7/TsaD (12, 13). Escherichia coli, tsaC (previously                       TsaD mitochondrial ortholog Qri7p sufficient synthesize t6A
yrdC) tsaD (previously ygjD) essential growth,                        vitro (17).
Saccharomyces cerevisiae, SUA5  tsaC homolog) KAE1  cytoplasmic member Kae1/Qri7/TsaD family) 
quired t6A synthesis (12, 13). Kae1 member KEOPS                            Received 17 June 2014 Accepted 12 July 2014
complex (kinase, putative endopeptidase, proteins                              Published ahead print 18 July 2014
small size) (14), known EKC (endopeptidase-like kinase                              Address correspondence ValÃ©rie CrÃ©cy-Lagard, vcrecy@ufl.edu.
chromatin-associated complex) (15). TsaC TsaD E. coli,                             P.C.T. B.E.Y. contributed equally work. bicarbonate, L-threonine, ATP, tRNA, suf-                            Supplemental material article http://dx.doi.org/10.1128
ficient form t6A vitro; TsaB (previously YeaZ) TsaE (pre-                         /EC.00147-14.
viously YjeE) required (10). result reproduced                            Copyright Â© 2014, American Society Microbiology. Rights Reserved.
using Bacillus subtilis orthologs, shown YwlC                        doi:10.1128/EC.00147-14
B. subtilis (YwlCBs; ortholog TsaC E. coli [TsaCEc]) 


1222   ec.asm.org                                          Eukaryotic Cell   p. 1222â€“1231                                              September 2014 Volume 13 Number 9
                                                                                                                                 Mitochondrial t6A Synthesis




FIG 1 Diversity biosynthesis pathway universal tRNA modification t6A. formation TC-AMP catalyzed enzyme family organisms (TsaC/Sua5). Sua5p contains TsaC domain plus additional C-terminal domain, called Sua5, characterized. transfer
threonylcarbamoyl (TC) tRNA, bacteria require TsaBDE, archaea eukaryotes use KEOPS complex (composed Kae1, Bud32, Cgi121, Pcc1
proteins; Gon7 exclusively fungi).



    S. cerevisiae, mitochondrial DNA (mtDNA) encodes                media, agar dropout (lacking uracil required mitochondrial tRNAs, shown                 [â«ºura], leucine, [â«ºleu], histidine [ ), purchased contain t6A (18). Qri7p shown localize mito-               Clontech (Palo Alto, CA) prepared recommended manu-
chondria organisms (19, 20), qri7âŒ¬ S. cerevisiae            facturer. Glucose (Glu; 2 , wt/vol), glycerol (Gly; 4 , wt/vol), 5-fluoro-
does grow glycerol, indicating mitochondrial defect (19,             orotic acid (5-FOA; 0.1 , wt/vol), G418 (300 â?®g/ml) used                                                                               appropriate. Yeast transformations carried using frozen compe-
21).  mitochondrial targeting sequence Qri7p                                                                               tent cells described previously (24), plating appropriate
deleted, Qri7p functionally replace Kae1p t6A synthesis                                                                               media. sua5::KANMX4 strain VDC9100 created PCR cytoplasm S. cerevisiae cells (12).  proposed         amplifying sua5::KanMX4 locus sua5::KANMX4/SUA5 dip- mitochondrial t6A minimal composed                  loid obtained Euroscarf oligonucleotides flanking allele. Sua5p Qri7p (11, 17).                                                PCR product transformed electroporation wild-
    questions remain answered complete                type BY4742 containing pBN204 (SUA5 URA3 plasmid) (13). Trans-
derstanding yeast mitochondrial pathway.               formants selected SDâ«ºura plates containing G418. passag-
clear TC-AMP, product Sua5p-catalyzed reaction,              ing uracil-containing media, strain cured pBN204 transported mitochondria Sua5 protein itself              counterselection 5-FOA. Disruption SUA5 confirmed PCR
imported organelle. Global subcellular localization stud-           using oligonucleotides annealing inside outside locus, ies S. cerevisiae reported Sua5p localize cytoplasm (20,         inside KANMX4. VDC9100 confirmed devoid t6A using 22). Second, Qri7, unlike bacterial counterparts, func-           high-performance liquid chromatography (HPLC) liquid chroma-
                                                                              tography-tandem mass spectrometry (LC-MS/MS) analyses listed 
tion TsaB TsaE proteins? bacteria, mainly
                                                                                  E. coli strains grown LB (1 , wt/vol, tryptone, 0.5 , wt/vol,
intracellular pathogens Mycoplasma, lost tsaB                yeast extract, 1 , wt/vol, salt; 1.5 , wt/vol, agar added plates)
tsaE (23). clear genes kept majority          37Â°C unless stated. necessary, LB supplemented sequenced bacteria date.  TC-AMP (produced TsaC                kanamycin (Km; 50 â?®g/ml), ampicillin (Ap; 100 â?®g/ml), chloram- Sua5p) used indifferently TsaBDE, KEOPS, Qri7p                phenicol (Cm; 35 â?®g/ml), anhydrotetracycline (aTc; 50 ng/ml), ara-
systems vitro, case vivo?            binose (Ara; 0.2 , wt/vol). Plasmids transformed E. coli TC-AMP intermediate highly unstable (16), likely            electroporation. drop dilution assays, E. coli cells grown sat-
t6A synthesis vivo requires protection mechanism                     uration overnight LB supplemented aTc appropriate
TC-AMP.                                                                       antibiotics diluted 10-fold increments prior wash
    work, validate hypothesis Sua5p participates          step remove aTc left culture media. â?®l dilution mitochondrial t6A synthesis showing Sua5p localizes             spotted appropriate media. halo plates, cultures
                                                                              grown saturation overnight LB supplemented aTc cytoplasm mitochondria alternative
                                                                              appropriate antibiotics diluted 500 times. ml diluted
translation start site explore possibility TC-AMP pro-
                                                                              culture added plates containing 25 ml agar media, excess
tection mechanism channeling heterologous comple-                 bacterial suspension immediately removed. Plates dried, mentation studies.                                                            10-â?®l drop aTc added surface plate shown Fig. S3
                                                                              supplemental material.
MATERIALS METHODS                                                             Plasmid construction protein expression. plasmids 
Strains growth conditions. Yeast strains grown yeast extract-     structed protein expression (Table 1) sequences primers peptone-dextrose (YPD; Difco Laboratories) 30Â°C. Synthetic minimal         restriction sites used cloning listed Table S1 supplemental


September 2014 Volume 13 Number 9                                                                                                         ec.asm.org 1223
Thiaville et al.



TABLE 1 Strains plasmids used study
Strain plasmid                      Relevant characteristic(s)                                                                Reference source
Yeast
  BY4741                  MATa his3âŒ¬1 leu2âŒ¬0 met15âŒ¬0 ura3âŒ¬0                                                         39
  BY4742                  MATâ?£ his3âŒ¬1 leu2âŒ¬0 lys2âŒ¬0 ura3âŒ¬0                                                          39
  YGL169w::GFP            MATa his3âŒ¬1 leu2âŒ¬0 met15âŒ¬0 ura3âŒ¬0 SUA5::GFP                                               22
  YDL104c::GFP            MATa his3âŒ¬1 leu2âŒ¬0 met15âŒ¬0 ura3âŒ¬0 QRI7::GFP                                               22
  VDC9054                 MATâ?£ his3âŒ¬1 leu2âŒ¬0 lys2âŒ¬0 ura3âŒ¬0 sua5::kanMX4 (pBN204)                                    study
  VDC9100                 MATâ?£ his3âŒ¬1 leu2âŒ¬0 lys2âŒ¬0 ura3âŒ¬0 sua5::kanMX4                                             study

E. coli
   DH5â?£                   Fâ«º gyrA462 endA1 âŒ¬(sr1-recA) mcrB mrr hsdS20(rBâ«º, mBâ«º) supE44 ara-14 galK2 lacY1          Invitrogen
                            proA2 rpsL20(Smr) xyl-5 â?­â«º leu mtl1
   BW25113                Fâ«º âŒ¬(araD-araB)567 âŒ¬lacZ4787(::rrnB-3) â?­â«º rph-1 âŒ¬(rhaD-rhaB)568 hsdR514                   E. coli genetic stock center
   VDC5789                BW25113 containing knRExTETrbs::tsaDEc                                                    12
   VDC5684                BW25113 containing knRExTETrbs::tsaCEc                                                    study
   VDC5806                VDC5789(pBAD24)                                                                           study
   VDC5732                VDC5684(pBAD24)                                                                           study
   VDC6116                VDC5684(pBY265.9)                                                                         study
   VDC6120                VDC5684(pBY270.2)                                                                         study
   VDC6126                VDC5789(pBY265.9)                                                                         study
   VDC6130                VDC5789(pBY270.2)                                                                         study
   VDC5926                VDC5789(pBY245.1)                                                                         study

Plasmids
  pBAD24                  bla, araC, PBAD                                                                           26
  pBAD33                  cat, araC, PBAD                                                                           26
  pUC19                   General cloning vector                                                                    40
  pRS313                  Yeast shuttle vector; HIS3                                                                41
  pBN204                  pYES::SUA5; URA3                                                                          13
  pYX122-mtGFP            Mitochondrial targeting GFP; HIS3                                                         25
  pYX142-mtRFP            Mitochondrial targeting RFP; LEU2                                                          Delahodde
  pPCT004                 pYX122-mtGFP fused 70 bp SUA5 cloned EcoRI/BamHI fragment                  study
  pPCT006                 pYX122-mtGFP fused 5=-truncated SUA5 cloned EcoRI/BamHI fragment                    study
  pPCT017                 pUC19::SUA5 cloned EcoRV fragment                                                      study
  pPCT019                 pUC19::SUA5(M10L) cloned EcoRV fragment                                                study
  pPCT025                 pYX122-mtGFP::SUA5 subcloned pPCT017 EcoRI/BamHI fragment                         study
  pPCT030                 pYX122-mtGFP::SUA5(M10L) subcloned pPCT019 EcoRI/BamHI fragment                   study
  pPCT036                 pYX122-mtGFP fused 70 bp SUA5(M10L) cloned EcoRI/BamHI fragment            study
  pPCT066                 Sua5(10-426) subcloned pPCT006 EcoRI/SmaI fragment pRS313 treated       study
                             EcoRI/EcoRV
   pPCT070                GAL promoter subcloned pBY137 SpeI/PvuII fragment pPCT066 digested           study
                             XbaI/SmaI
   pPCT074                GAL::tsaC subcloned pBY135 SpeI/PmeI fragment pRS313 digested SpeI      study
                             EcoRV
   pPCT075                GAL::ywlC subcloned pBY137 SpeI/PmeI fragment pRS313 digested SpeI      study
                             EcoRV
   pPCT076                Site-directed mutagenesis pBY176 change AUG SUA5 CUG                study
   pPCT078                Site-directed mutagenesis pBY176 change second AUG SUA5 CUG               study
   pBY130                 pBAD24::SUA5                                                                              13
   pBY135                 pYesDEST52::tsaCEc; bla, URA3                                                             13
   pBY137                 pYesDEST52::ywlCBs; bla, URA3                                                             13
   pBY176                 pRS313::SUA5Sc; bla, URA3                                                                 13
   pBY265.9               pBY130::QRI7 (primer pair 18/19)                                                          study
   pBY270.2               pBAD24::QRI7 (primer pair 18/19)                                                          study
   pBY245.1               pBAD24::tsaD (primer pair 16/17)                                                          study
   pBY343.2               pBAD33=::tsaD (primer pair 22/23); pBAD33= pBAD33 cut EcoRV SmaI,             study
                             partially removing araC PBAD promoter; tsaD constitutively expressed                              PBAD promoter brought forward primer
   pBY344.2               pBAD33=::QRI7 (primer pair 20/21)                                                         study
   pBY346.2               pBY344.2::rbsSUA5Met1 (primer pair 24/26); SUA5 cloned methionine       study
   pBY347.6               pBY344.2::rbsSUA5Met10 (primer pair 25/26); SUA5 cloned second methionine     study




1224    ec.asm.org                                                                                                               Eukaryotic Cell
                                                                                                                             Mitochondrial t6A Synthesis



material. plasmid constructs confirmed sequencing. clon-    screen. growth curves presented averages 5 biological repli-
ing procedure protein purification S. cerevisiae Sua5 (Sua5Sc)   cates. Significance determined using 2-way analysis variance
described (11). QRI7 amplified PCR using genomic           (ANOVA) Fisherâ€™s significant differences (LSD) Prism 6
DNA S. cerevisiae strain S288C (ATCC) appropriate oligonucle-      (GraphPad).
otides  Table S1). 90 nucleotides QRI7, encoding mi-       Preparation bulk tRNA detection t6A. Bulk tRNA pre-
tochondrial targeting sequence, deleted. gene carried hexahis-   pared double phenol-chloroform extraction, nucleoside prepara-
tidine tag 3= end subsequently cloned pET28a            tions prepared previously described (13). tRNA extractions
expression vector (Novagen) NcoI NotI restriction sites.            performed triplicate independent cultures. t6A detected
     Plasmid construction yeast vivo assays. Plasmid construction    HPLC described previously (27) LC-MS/MS described microscopy based yeast mitochondrion-targeting green         reference 13. MS/MS fragmentation data synthesized t6A stan-
fluorescent protein (GFP) plasmid, pYX122-mtGFP (25). pYX122-               dard provided Darrell Davis (University Utah) used confirm
mtGFP digested EcoRI BamHI remove preSu9 mito-          presence t6A.
chondrion-targeting sequence. SUA5 BY4742 PCR amplified                tRNA production purification. E. coli tRNAAsn(GUU) oligonucleotides listed Table S1 supplemental material    tRNALys(UUU) overexpressed E. coli XL1-Blue cells (Agilent Tech-
create various forms Sua5-GFP. PCR products digested       nologies) purified described previously (11). purification,
EcoRI BamHI ligated using T4 DNA ligase (NEB) simi-        RNAs loaded 8 M urea, 12  polyacrylamide gel, band
larly digested pYX122-mtGFP. Plasmids complementation assays            corresponding overexpressed tRNA cut  tRNA eluted listed Table 1 created subcloning components previously     gel elution buffer (EB; 0.1  SDS, 0.5 M ammonium acetate [NH4Ac],
described plasmids. Site-directed mutagenesis performed using       10 mM MgAc, 1 mM EDTA), precipitated, suspended water. QuikChange lightning mutagenesis kit (Agilent, Santa Clara, CA) fol-     favor correct folding tRNAs, solution heated 70Â°C, cooled
lowing manufacturerâ€™s recommendations.                                  slowly room temperature, stored â«º80Â°C.
     Plasmid construction E. coli vivo assays. E. coli tsaD              vitro assay synthesis t6A-modified tRNA. vitro
(NP_417536) amplified PCR genomic DNA prepared             assay performed essentially described previously (11). reaction
E. coli K-12 MG1655 oligonucleotides listed Table S1         performed final volume 50 â?®l containing 4 â?®M Sua5p 5
supplemental material. yeast SUA5 (NP_011346) QRI7                  â?®M Qri7p, 4.8 â?®M tRNA, 18.2 â?®M [14C]L-threonine (0.05 mCi, 55
(NP_010179) genes amplified S. cerevisiae BY4741 genomic          Ci/mol; Hartmann Analytic) reaction buffer (RB). 40 min DNA oligonucleotides listed Table S1. PCR fragments di-        incubation 32Â°C, macromolecules precipitated addition gested appropriate restriction enzymes cloning pBAD     1 ml trichloroacetic acid 15  (TCA) incubated ice 1 h.
pBAD-derived vectors (26). QRI7 cloned putative mito-       Precipitated material applied prewet glass microfiber GF/F filters
chondrion-targeting sequence (corresponding 30 amino ac-       (Whatman) using vacuum apparatus (Millipore). Filters washed
                                                                            3 ml 5  TCA 3 ml 95  ethanol (EtOH) dried. Radio-
ids). ribosomal binding site restriction sites added                                                                             activity recorded liquid scintillation analyzer (Packard) av-
primer sequences cloning purposes described Table S1. SUA5                                                                             erage counts minute (cpm) 2 min. incorporated
cloned (M1) second methionine (M10).
                                                                            threonine calculated standard curve obtained different
     Microscopy. determine localization Sua5-GFP, yeast                                                                             concentrations [14C]L-threonine spotted filters (1 pmol â«½ 102.8
cotransformed mitochondrial marker pYX142-RFP                                                                             cpm). yield reaction calculated [cpm (assay) â«º cpm Sua5-GFP constructs, transformants selected SDâ«º
                                                                            (background)/102.8]/(pmol tRNA) â«» 100. leu plates. microscopy, cells grown mid-log phase dropout media containing 1  glucose 3  glycerol. Cells washed water prior analysis 100â«» magnification Leica DM       RESULTS
IRE2 confocal microscope using MetaMorph microscopy automation              Sua5p targeted cytoplasm mitochondria image analysis software (Molecular Devices, Sunnyvale, CA). Decon-      alternate frame AUG start sites. vitro, Qri7p Sua5p volution pseudocoloring images performed using Meta-             produce t6A additional proteins, separated
Morph, final figures constructed using Photoshop CS6 (Adobe).      2-kDa molecular size cutoff membrane, noticeably
     Recombinant protein expression purification. expression        t6A produced Qri7p Sua5p separated purification recombinant Sua5p S. cerevisiae TsaC, TsaD,
                                                                             precise increase difficult determine Fig. 3A Wan
TsaB, TsaE E. coli described previously (11). Recombinant
Qri7p expressed E. coli Rosetta2 (DE3) pLysS (Novagen). Protein
                                                                            et al. [17]). Close examination SUA5 open reading frame
overexpression induced overnight express instant TB medium           (ORF) revealed frame AUG codons located 28
(Novagen) supplemented 10  glycerol. Cells collected cen-      nucleotides (Fig. 2A), postulated  vivo, Sua5p trifugation, suspended lysis buffer (LBf; 50 mM Tris-HCl, pH 8, 500      functional cytoplasm mitochondria, SUA5
mM NaCl, 10  glycerol, 0.01  [vol/vol] Triton X-100, 10 mM imidazole,       homolog encoded mtDNA. mitochondrial targeting
protease inhibitor cocktail [Roche]), sonicated ice. tagged      prediction software iPSORT (28) predicted mitochondrion-tar-
proteins soluble fraction purified gravity-flow chroma-    geting sequence isoform started AUG
tography nickel-nitrilotriacetic acid (Ni-NTA) resin column (Qia-       referred M1, methionine position 1) did gen) according manufacturerâ€™s recommendations. Fractions       predict mitochondrial targeting sequence second AUG
terest pooled, concentrated, injected Superdex 200 column     (M10, methionine position 10 Sua5). suggested (GE Healthcare). Fractions containing pure proteins concentrated       long form Sua5p translated AUG mitochon- stored â«º80Â°C storage buffer (SB; 50 mM Tris-HCl, pH 8, 500
                                                                            drion-targeted protein, short form Sua5p, translated
mM NaCl, 10  glycerol).
     Yeast growth assays. Growth curves performed using Bio-
                                                                            second AUG, remain cytoplasmic.
screen C MBR (Oy Growth Curves AB , Finland) 30Â°C maxi-             test predictions, performed fluorescence micros-
mum shaking. 250-â?®l culture used  5 biological       copy chromosomally encoded Sua5-GFP fusion, 
replicates used condition. Yeast cultures grown       trol, tested Kae1-GFP Qri7-GFP. low abun-
SD saturation, normalized optical density 600 nm (OD600)    dance proteins (estimated 600 1, diluted 200 times SD loaded Bio-       molecules cell Sua5p [20]), signal weak pro-


September 2014 Volume 13 Number 9                                                                                                     ec.asm.org 1225
Thiaville et al.




FIG 2 Subcellular localization Sua5p.   SUA5 ORF contains frame AUG codons located 28 nucleotides. iPSORT (28) predicts Sua5p
translated AUG target mitochondria. TsaC-like domain Sua5 domain indicated scale. (B) Sua5::GFP localization using
confocal microscopy 100â«» magnification. Wild-type BY4741 transformed plasmids expressing RFP targeted mitochondria Sua5::GFP
fusions. Row 1, control. Row 2, RFP fused Fo-ATPase mitochondrial targeting sequence. length, wild-type Sua5::GFP indicates cytoplasmic mitochondrial targeting Sua5p. Colocalization RFP GFP mitochondria indicated yellow merged image. Row 3, residues 10 426 Sua5
fused GFP [Sua5(10-426)::GFP] targets cytoplasm. Row 4, substitution M10L length Sua5 (Sua5-M10L::GFP) enhances localization mitochondria. Row 5, 25 residues Sua5p [Sua5(1-25)] sufficient dual targeting. GFP located cytoplasm mitochondria. (6)
Sua5-M10L(1-25)::GFP targets mitochondria.


duced images greatly overexposed, did indicate               cytoplasm mitochondria, second AUG mitochondrial localization Sua5p (data shown).                 mutated CUG, GFP localized mitochondria, sup-
crease level Sua5p cell, constructed Sua5-GFP                  porting conclusion Sua5p target mitochondria.
fusions control constitutive triosephosphate                       localization function Sua5-GFP confirmed isomerase (TPI) promoter ARS/CEN vector pYX122-                          cotransforming VDC9100 (sua5âŒ¬) pYX142-RFP mtGFP (25). Su9 mitochondrial targeting sequence                         Sua5-GFP plasmids. targeting Sua5-GFP sua5âŒ¬ mimics pYX122-mtGFP replaced SUA5 lacking stop codon,                       results seen wild-type BY4741. length Sua5-GFP targeted creating plasmid pPCT025. Wild-type S. cerevisiae BY4741                    cytoplasm mitochondria. Sua5(10-426)-GFP targeted ex-
cotransformed pPCT025 pYX142-mtRFP  specifically                    clusively cytoplasm, Sua5(M10L)-GFP targeted exclusively
label mitochondria red fluorescent protein  gift AgnÃ¨s              mitochondria  Fig. S1 supplemental material).
Delahodde]), transformants examined 100â«» confo-                         TC-AMP produced cytoplasm sufficient mi-
cal microscopy. experiment revealed uniform distribution                 tochondrial function. test TC-AMP shuttled GFP cytoplasm foci GFP mitochondria              cytoplasm mitochondria, series plasmids 
colocalizing mitochondrion-targeted red fluorescent protein                structed encoding Sua5p targeted cytoplasm  TsaC
(RFP) (Fig. 2B, row 2). examined 5=-truncated form                 E. coli, Sua5 (YwlC) B. subtilis. mimic nat-
Sua5p created cloning Sua5(10-426) pYX122-mtGFP, giving                 urally low expression SUA5, PGAL fusions low-copy-
pPCT006. Sua5p starting second Met (M10) localized exclu-                number CEN/ARS plasmid pRS313 constructed. PGAL sively cytoplasm (Fig. 2B, row 3). Additionally, created            known leaky, presence glucose (29). 
point mutation SUA5 altering second AUG CUG (M10L)                    Sua5(10-426) cloned PGAL pYesDEST52 cloned SUA5(M10L) pYX122-mtGFP, creating pPCT030.                      pRS313 (creating pPCT070), allowing Sua5(10-426) (targeted seen Fig. 2B, row 4, M10L substitution Sua5p enhances              cytoplasm) expressed low levels absence localization mitochondria, eliminating Sua5-GFP               galactose inducer. eliminates possible interfering growth
cytoplasm. confirm N terminus Sua5p respon-                  galactose testing growth glycerol carbon
sible targeting GFP mitochondria, cloned 70             source. PGAL::tsaCEc (pPCT074), PGAL::ywlCBs (pPCT075), nucleotides SUA5 SUA5(M10L) pYX122-mtGFP, creat-                    PGAL::SUA5Sc (pBY176) constructed using plasmid,
ing pPCT004 pPCT036, respectively. seen Fig. 2B, rows                 pRS313, backbone.
5 6, 70 nucleotides SUA5 dual-localized GFP                 Yeast strains mutations SUA5 slow growth 

1226    ec.asm.org                                                                                                                             Eukaryotic Cell
                                                                                                                                 Mitochondrial t6A Synthesis




FIG 3 Complementation sua5âŒ¬. Growth curves performed Bioscreen C. Points represent averages biological replicates. Error bars represent standard errors means. pBY176 contains SUA5 plus 200 nt sequence upstream cloned pRS313. pPCT076 contains M1L mutation SUA5.
pPCT078 contains M10L mutation SUA5.   Complementation sua5âŒ¬ 2  glucose. (B) Growth 2  glucose-containing plates day 4. microliter drops 10-fold dilutions beginning OD600 0.1. (C) Complementation sua5âŒ¬ 2  glycerol. (D) panel B, growth 2  glycerol-containing plates day 10 examined.



glucose-containing media utilize nonfermentable                 SUA5-containing plasmids effect growth sugar alcohol glycerol sole carbon source (13, 30). shown           BY4741 using glucose glycerol carbon source (Fig. 3). Fig. S2 supplemental material, supplying PGAL::SUA5(10-426)             expression SUA5 AUG second AUG mu-
PGAL::tsaCEc, PGAL:: ywlCBs, PGAL::SUA5Sc trans suppressed               tated complemented slow growth sua5âŒ¬ levels growth defect sua5âŒ¬ strain using glucose carbon                wild-type SUA5 glucose used carbon source (Fig.
source, implying corresponding proteins functional                 3A B).  glycerol used carbon source, cytoplasm.  PGAL::SUA5Sc restored growth                   expression wild-type SUA5 SUA5 second AUG
glycerol, albeit longer lag phase.                                      mutated [encoding Sua5(M10L)] complemented lack growth
   results suggest proteins produced TC-               sua5âŒ¬ mutant (Fig. 3C D). expression SUA5 AMP cytoplasm suppress glucose growth defect                 mutation AUG did allow complementation. TC-AMP shuttled mitochondria,                         complementation assay corroborates GFP localization
seen inability PGAL::SUA5(10-426), PGAL::tsaCEc, PGAL::           data presented earlier. Sua5p dual targeted cyto-
ywlCBs variants grow glycerol.                                           plasm mitochondria use alternative trans-
   Sua5p targeted mitochondria grow glyc-                 lational starts, translation AUG required erol. directly test mitochondrion-targeting Sua5p                 localization mitochondria.
quired mitochondrial function, series plasmids pre-                  vitro, Qri7p function Sua5p TsaCEc.
pared use native SUA5 promoter drive constructs                    Wan et al. showed Qri7p Sua5p S. cerevisiae targeting Sua5p cytoplasm, mitochondria,  Site-                 necessary sufficient synthesize t6A vitro, repro-
directed mutagenesis performed pBY176 (SUA5 plus 200                    duced result using different assay (10, 11) (Fig. 4A). nt upstream sequence cloned low-copy-number plasmid                   assay measures incorporation radioactive threonine pRS313) mutate methionine leucine (M1L), creating              TCA-precipitated material corresponds formation pPCT076, second methionine leucine (M10L), creating                  t6A-modified tRNA (11). shown Fig. 4A, significant synthe-
pPCT078. SUA5-containing plasmids, pa-                sis t6A obtained ATP-dependent manner rental pRS313, transformed BY4741 sua5âŒ¬ mu-                    Sua5p Qri7p present reaction mixture. tant selection SD agar.                                            contrast, background signal levels measured using
   Mitochondrial function assayed testing growth                 Sua5p Qri7p  indicating necessary nonfermentable carbon source glycerol. expression               reaction place. asked heterologous 

September 2014 Volume 13 Number 9                                                                                                         ec.asm.org 1227
Thiaville et al.




FIG 4 vitro synthesis t6A.   Qri7 Sua5 proteins S. cerevisiae catalyze formation t6A ATP-dependent fashion. reaction mixture
contained 4 â?®M Sua5p 5 â?®M Qri7p, 4.8 â?®M E. coli tRNALysUUU, 18.2 â?®M [14C]L-threonine reaction buffer (RB). 40 min incubation 32Â°C,
macromolecules precipitated trichloroacetic acid, radioactivity contained tRNA recorded using liquid scintillation analyzer. Error bars
indicate standard deviations means obtained independent experiments. (B) Heterologous composed TsaC Qri7p functional vitro. reaction mixture contained 3 â?®M proteins, indicated x axis, 4.8 â?®M E. coli tRNAAsn(GUU), 18.2 â?®M [14C]L-threonine reaction buffer (RB). 35 min incubation 37Â°C, macromolecules precipitated trichloroacetic acid. Radioactivity contained tRNA recorded using liquid scintillation analyzer. Error bars indicate standard deviations means obtained independent experiments.


composed TsaCEc, bacterial homolog Sua5p, Qri7p                   press yeast genes. suppressors appear E. catalyze t6A synthesis vitro. shown Fig. 4B, TsaC            coli tsaD gene expressed vector  Fig. S3; sup-
Qri7p result 83  modified tRNA compared                         pressors seen inset). Additionally, low level comple-
TsaCDBE control, indicating Qri7/TsaCEc combination                 mentation seen presence Qri7p condi-
functional vitro.                                                            tions small chromosomal E. coli tsaD gene
    vivo, Qri7p requires Sua5p does function                    produced. diameter halos aTc-dependent
TsaCEc. Surprisingly, contrast vitro results,             growth slightly larger PTET::tsaD strain expressing expression Qri7p failed complement essential               Qri7p vector control  Fig. S3).
phenotype E. coli strain expressing tsaD. shown Fig.                ratio Qri7p Sua5p critical allowing 5A, E. coli PTET::tsaD strain transformed pBAD24 deriv-                complementation PTET::tsaD strain, expressing QRI7
atives expressing QRI7 (pBY270.2) did grow absence                SUA5 lower-copy-number plasmid (P15a ori) aTc (required induction PTET) presence arabi-              constitutive promoter (PBLA) did allow growth PTET::
nose. QRI7 SUA5 expressed operon                       tsaD strain absence aTc (Fig. 5C) did der PBAD promoter (pBY265.9)  diagram genetic                  absence induction high-copy-number plasmid pBAD24
structs Fig. 5B), partial complementation                       (ColE1 ori) (Fig. 5A). Expressing E. coli tsaD plasmid
(reduced growth smaller colonies compared complemen-                     (pBY343.2) did allow growth aTc, establishing tation TsaD) observed (Fig. 5A), suggesting Qri7p                 PBLA promoter functional (Fig. 5C). ensure SUA5(M1) TsaC able function vivo, Qri7p             SUA5(M10) functional E. coli, plasmids PBLA::QRI7::
Sua5p able sustain partial growth. plasmid             SUA5(M1) (pBY346.2) PBLA::QRI7::SUA5(M10) (pBY347.6)
expressing QRI7 SUA5 transformed PTET::tsaC                    tested complementation PTET::tsaC strain. strain, allowed grow absence aTc, establishing           strain background, plasmids allowed growth ab- SUA5 functional setup. Interestingly, complemen-                sence aTc, establishing SUA5(M1) SUA5(M10) tation robust absence aTc arabinose                 functional E. coli (Fig. 5D). strain expressing yeast SUA5 QRI7 genes compared strain expressing E. coli tsaD gene.                                 DISCUSSION
    Similar results obtained halo assays, diluted               eukaryotes, tRNA modification enzymes targeted cytoplasm
cultures spread plates 10-â?®l drop aTc                  organelles encoded single nuclear gene. dual
added center surface plate  Fig. S3             targeting modification enzymes observed supplemental material). aTc diffuses plate                  universally conserved tRNA modifications. yeast
provides gradient induction PTET. Partial complementa-                 pseudouridylation enzymes Mod5p, enzyme responsi-
tion observed QRI7 SUA5 expressed                  ble insertion N6-isopentenylasenosine (i6A37), targeted operon PBAD, halo test, suppressors clearly                 cytoplasm mitochondria (31, 32). Similarly,
appear zone lower levels aTc strain ex-              Trm5p, tRNA (guanine-N1-)-methyltransferase modifies mi-


1228    ec.asm.org                                                                                                                              Eukaryotic Cell
                                                                                                                                      Mitochondrial t6A Synthesis




FIG 5 Qri7 TsaC able function vivo, Qri7 Sua5 able sustain growth.   Dilution drops E. coli PTET::
tsaD(pBAD24) strain derivatives expressing QRI7 did grow absence aTc (required induction PTET) presence arabinose. SUA5 QRI7 expressed operon PBAD promoter, complementation observed, suggesting Qri7 TsaCEc able function vivo, Qri7 Sua5 able sustain partial growth. E. coli PTET::tsaC(PBAD::QRI7) strain does grow aTc, PBAD::SUA5::QRI7 strain grow aTc, validating function operon. (B) Diagram construction inducible strains plasmids. (C) Direct
transformation low-copy-number plasmids constitutive expression PBLA PTET::tsaD strain plating aTc. Qri7::Sua5(M1) Qri7::Sua5(M10) synthetic operons sustain growth absence aTc. Providing tsaD trans using setup allows growth. (D) Direct
transformation low-copy-number plasmids constitutive expression PBLA PTET::tsaC strain plating aTc. Sua5 translated second AUG support growth E. coli absence aTc.


tochondrial tRNA methylates guanosine position 37                     â«¹4 (Fig. 2A). presence frame AUGs N termi-
(m1G37) tRNAs nucleus, dual localization.           nus TsaC/Sua5 proteins conserved Arabidopsis thaliana long form exclusively mitochondria N-termi-                 Homo sapiens eukaryotic genomes sequenced
nally truncated form (translated second internal, frame                 date  Fig. S4 supplemental material), suggesting AUG start site) exclusively nucleus (22, 33, 34).                dual-targeting mechanism conserved. plants, TsaC Sua5-GFP data presented strongly suggest similar scenario              targeted mitochondria chloroplasts addition Sua5p. nucleotide context surrounding AUGs                    localized cytoplasm, copy TsaC, located
nonoptimum Kozak consensus, U â«º3 â«¹4                    nuclear genome, plant genomes analyzed. AUG  yeast, U â«º3 reduces expression 2-fold [35])              prediction experimentally validated.
stronger Kozak sequence second AUG, G â«º3                     reproduced results reported Wan et al. showing 

September 2014 Volume 13 Number 9                                                                                                               ec.asm.org 1229
Thiaville et al.



t6A-modified tRNA formed vitro joint action Sua5p        (17), indicating t6A modification required normal Qri7p ATP-dependent fashion (17). maximum                  functioning mitochondria. data indicate TC- modified tRNA 16  assay conditions;           AMP produced cytoplasm transported  sufficient significant, high reported Wan      amounts) mitochondrial matrix, line colleagues (80  modified tRNA).  tRNA sub-            unstable nature intermediate.
strate used hypomodified tRNA overexpressed               S. cerevisiae, Qri7p fully rescue t6A synthesis E. coli. Unfortunately, know proportion tRNAs        kae1âŒ¬ background, partially complement telom-
lacking t6A modification. examination kinetics          ere-length defect, indicating KEOPS proteins action revealed comparable maximal rate modification: 0.7           functions cell (17). similar observa-
modified tRNA/min versus 0.6  modified tRNA/min reaction             tion E. coli cells, cells relying Qri7/Sua5 t6A
reported Wan et al.  judged Fig. 2G Wan et al.;       synthesis healthy cells expressing TsaD.  Fig. S4 supplemental material).          data suggest  bacteria, TsaD TsaDEB complex tRNA reaction modified  Materials        functions cell replaced Qri7p, explain-
Methods; Fig. S5);  vitro reaction         ing observed partial complementation. Interestingly, genomic
forms equally better reported Wan col-          context data implicate TsaDEB synthesis peptidoglycan
leagues. modified tRNA increased linear fashion         bacteria (38). pursuing hypothesis additional 30 min incubation, rate decreases,         genetic experiments.
haps instability proteins. addition, observed        Sua5p localization phenotype data presented  similar maximal rate cytoplasmic composed            combination vitro data published previously (17),
Sua5p KEOPS proteins (0.6  modified tRNA/min), indicat-              reproduced current study, firmly establish 
ing mitochondrial cytoplasmic systems perform              yeast, Sua5p Qri7p colocalize mitochondria equally vitro  Fig. S5). observation line    proteins required introduce t6A modifications mi- vivo data demonstrated Sua5p Qri7p fully             tochondrial tRNAs, Sua5p localize mitochondria
restore t6A levels kae1âŒ¬ mutant cells S. cerevisiae (17).          growth nonfermentable carbon source glycerol.     observed heterologous TsaC Qri7p           implies TC-AMP transported cytoplasm performs vitro (80  t6A formed compared            sufficient amounts mitochondrial function TC-AMP
trol) (Fig. 4B) does complement TsaD mutant vivo.         produced organelle. data indicate TC-AMP intermediate produced TsaC captured Qri7p vitro vivo. likely     ACKNOWLEDGMENTS vivo conditions, TC-AMP intermediate            work supported National Institutes Health (grant num-
sequestered molecules crowded interior cell       ber R01 GM70641 V.D.C.-L.) Agence Nationale Recher-
 nucleotide-binding proteins) destroyed             che (ANR-09-BLAN-0349 P.F.). P.C.T. funded Cha-
Qri7p captures   data suggest normal t6A       teaubriand Fellowship French Embassy United States. L.P
synthesis cell requires TC-AMP intermediate           received Ph.D. fellowship ENS Lyon.
delivered Kae1p/TsaD/Qri7p active site. delivery               thank AgnÃ¨s Delahodde sharing pYX142-mtRFP prior pub-
mechanism achieved direct contact               lication Bruno Collinet Wenhua Zhang providing                                                                          runoff transcripts tRNA genes.
TsaC/Sua5p Kae1p/TsaD/Qri7p, followed channeling TC-AMP TsaC/Sua5p active site Kae1p/TsaD/
                                                                         REFERENCES
Qri7p. hypothesis strongly supported data showing
                                                                          1. Agris PF, Vendeix FA, Graham PWD. 2007. tRNAâ€™s wobble decoding Qri7p complement TsaD mutant vivo                  genome: 40 years modification. J. Mol. Biol. 366:1â€“13. http://dx.doi
Sua5p present, TsaC functional present            .org/10.1016/j.jmb.2006.11.046. cell. support interpretation data comes       2. Grosjean H, Henau S, Doi T, Yamane  Ohtsuka E, Ikehara M, structural work obtained protein TobZ (36).                 Beauchemin N, Nicoghosian K, Cedergren R. 1987. vivo stability,
                                                                             maturation aminoacylation anticodon-substituted Escherichia coli
TobZ highly relevant t6A biosynthesis composed
                                                                             initiator methionine tRNAs. Eur. J. Biochem. 166:325â€“332. http://dx.doi TsaC-like domain Kae1-like domain. Parthier col-                .org/10.1111/j.1432-1033.1987.tb13518.x.
leagues showed TsaC-like domain catalyzes formation          3. Phizicky EM, Alfonzo JD. 2010. modifications benefit tRNAs? intermediate carbamoyladenylate channeled             FEBS Lett. 584:265â€“271. http://dx.doi.org/10.1016/j.febslet.2009.11.049. Kae1-like domain, site carbamoyl transfer (36).          4. DÃ­az  Ehrenberg M. 1991. ms2i6A deficiency enhances proofreading                                                                              translation. J. Mol. Biol. 222:1161â€“1171. http://dx.doi.org/10.1016/0022 TsaC/Sua5 TsaD/Kae1/Qri7 families constant                  -2836(91)90599-2. t6A-forming systems, likely systems operate    5. Morin  Auxilien S, Senger B, Tewari R, Grosjean H. 1998. Structural channeling TC-AMP. line prediction, stable                requirements enzymatic formation threonylcarbamoyladenosine
interaction TsaC TsaD reported (10);                (t6A) tRNA: vivo study Xenopus laevis oocytes. RNA 4:24 â€“37.
                                                                          6. Phizicky EM, Hopper AK. 2010. tRNA biology charges   global interactome data Sua5p did identify Kae1p                                                                              Genes Dev. 24:1832â€“1860. http://dx.doi.org/10.1101/gad.1956510.
Qri7p proteins interactants, suggesting proteins        7. Elkins BN, Keller EB. 1974. enzymatic synthesis N-(purin-6-
engaged transient interaction (37). experimental work             ylcarbamoyl)threonine, anticodon-adjacent base transfer ribo- needed order test prediction.                                  nucleic acid. Biochemistry 13:4622â€“ 4628. http://dx.doi.org/10.1021
    demonstrated cells containing cytoplasmic ver-            /bi00719a024.
                                                                          8. Sibler AP, Dirheimer G, Martin RP. 1985. Yeast mitochondrial tRNAIle
sion Sua5p presented mitochondrial defect, cells            tRNAMetm: nucleotide sequence codon recognition patterns. unable grow nonfermentable carbon source glyc-                Nucleic Acids Res. 13:1341â€“1345. http://dx.doi.org/10.1093/nar/13.4
erol. phenotype observed qri7âŒ¬ S. cerevisiae             .1341.



1230    ec.asm.org                                                                                                                       Eukaryotic Cell
                                                                                                                                         Mitochondrial t6A Synthesis



 9. KÃ¶rner  SÃ¶ll D. 1974. N-(purin-6-ylcarbamoyl)threonine: biosynthesis             transformed high efficiency using LiAc/SS carrier DNA/PEG
    vitro transfer RNA enzyme purified Escherichia coli. FEBS         method. Nat. Protoc. 2:1â€“ 4. http://dx.doi.org/10.1038/nprot.2007.17.
    Lett. 39:301â€“306. http://dx.doi.org/10.1016/0014-5793(74)80135-3.            25.   Westermann B, Neupert W. 2000. Mitochondria-targeted green fluores-
10. Deutsch C, El Yacoubi B, CrÃ©cy-Lagard V, Iwata-Reuyl D. 2012.                   cent proteins: convenient tools study organelle biogenesis     Biosynthesis threonylcarbamoyl adenosine (t6A), universal tRNA nu-            Saccharomyces cerevisiae. Yeast 16:1421â€“1427. http://dx.doi.org/10.1002
    cleoside. J. Biol. Chem. 287:13666 â€“13673. http://dx.doi.org/10.1074/jbc           /1097-0061(200011)16:15â¬?1421::AID-YEA624â¬Ž3.0 2-U.
    .M112.344028.                                                                26.   Guzman LM, Belin D, Carson MJ, Beckwith J. 1995. Tight regulation,
11. Perrochia L, Crozat E, Hecker  Zhang W, Bareille J, Collinet B, van              modulation, high-level expression vectors containing arabi-
    Tilbeurgh H, Forterre P, Basta T. 2013. vitro biosynthesis univer-         nose PBAD promoter. J. Bacteriol. 177:4121â€“ 4130.
    sal t6A tRNA modification Archaea Eukarya. Nucleic Acids Res.         27.   Pomerantz SC, McCloskey JA. 1990. Analysis RNA hydrolyzates     41:1953â€“1964. http://dx.doi.org/10.1093/nar/gks1287.                               liquid chromatography-mass spectrometry. Methods Enzymol. 193:796 â€“
12. El Yacoubi B, Hatin  Deutsch C, Kahveci T, Rousset J-P, Iwata-Reuyl              824. http://dx.doi.org/10.1016/0076-6879(90)93452-Q.
    D, Murzin AG, CrÃ©cy-Lagard V. 2011. role universal Kae1/        28.   Bannai H, Tamada Y, Maruyama O, Nakai K, Miyano S. 2002. Extensive
    Qri7/YgjD (COG0533) family tRNA modification. EMBO J. 30:882â€“                   feature detection N-terminal protein sorting signals. Bioinformatics
    893. http://dx.doi.org/10.1038/emboj.2010.363.                                     18:298 â€“305. http://dx.doi.org/10.1093/bioinformatics/18.2.298.
13. El Yacoubi B, Lyons B, Cruz Y, Reddy R, Nordin B, Agnelli F, Wil-            29.   Kristoffersen P, Jensen GB, Gerdes K, Piskur J. 2000. Bacterial toxin-
    liamson JR, Schimmel P, Swairjo MA, CrÃ©cy-Lagard V. 2009.                   antitoxin gene containment control yeast cells. Appl. Environ.
    universal YrdC/Sua5 family required formation threonylcar-           Microbiol. 66:5524 â€“5526. http://dx.doi.org/10.1128/AEM.66.12.5524
    bamoyladenosine tRNA. Nucleic Acids Res. 37:2894 â€“2909. http://dx               -5526.2000.
    .doi.org/10.1093/nar/gkp152.                                                 30.   Lin CA, Ellis SR, True HL. 2010. Sua5 protein essential normal
14. Downey M, Houlsworth R, Maringele L, Rollie  Brehme M, Galicia S,                translational regulation yeast. Mol. Cell. Biol. 30:354 â€“363. http://dx.doi
    Guillard S, Partington M, Zubko MK, Krogan NJ, Emili  Greenblatt                 .org/10.1128/MCB.00754-09.
    JF, Harrington L, Lydall D, Durocher D. 2006. genome-wide screen           31.   Gillman EC, Slusher LB, Martin NC, Hopper AK. 1991. MOD5 trans-
    identifies evolutionarily conserved KEOPS complex telomere reg-           lation initiation sites determine N6-isopentenyladenosine modification     ulator. Cell 124:1155â€“1168. http://dx.doi.org/10.1016/j.cell.2005.12.044.          mitochondrial cytoplasmic tRNA. Mol. Cell. Biol. 11:2382â€“2390.
15. Kisseleva-Romanova E, Lopreiato R, Baudin-Baillieu  Rousselle J-C,         32.   Behm-Ansmant  Grosjean H, Massenet S, Motorin Y, Branlant C.
    Ilan L, Hofmann K, Namane  Mann C, Libri D. 2006. Yeast homolog                  2004. Pseudouridylation position 32 mitochondrial cytoplasmic
    cancer-testis antigen defines new transcription complex. EMBO J.            tRNAs requires distinct enzymes Saccharomyces cerevisiae. J. Biol.
                                                                                       Chem. 279:52998 â€“53006. http://dx.doi.org/10.1074/jbc.M409581200.
    25:3576 â€“3585. http://dx.doi.org/10.1038/sj.emboj.7601235.
                                                                                 33.   Lee C, Kramer G, Graham  Appling DR. 2007. Yeast mitochondrial
16. Lauhon CT. 2012. Mechanism N6-threonylcarbamoyladenonsine
                                                                                       initiator tRNA methylated guanosine 37 Trm5-encoded tRNA
    (t6A) biosynthesis: isolation characterization intermediate
                                                                                       (guanine-N1-)-methyltransferase. J. Biol. Chem. 282:27744 â€“27753. http:
    threonylcarbamoyl-AMP. Biochemistry 51:8950 â€“ 8963. http://dx.doi.org
                                                                                       //dx.doi.org/10.1074/jbc.M704572200.
    /10.1021/bi301233d.
                                                                                 34.   BjÃ¶rk GR, Jacobsson K, Nilsson K, Johansson MJ, BystrÃ¶m  Persson
17. Wan LCK, Mao DYL, Neculai D, Strecker J, Chiovitti D, Kurinov 
                                                                                       OP. 2001. primordial tRNA modification required evolution     Poda G, Thevakumaran N, Yuan F, Szilard RK, Lissina E, Nislow C,                   life? EMBO J. 20:231â€“239. http://dx.doi.org/10.1093/emboj/20.1.231.
    Caudy AA, Durocher D, Sicheri F. 2013. Reconstitution character-         35.   Romanos MA, Scorer CA, Clare JJ. 1992. Foreign gene expression yeast:     ization eukaryotic N6-threonylcarbamoylation tRNA using mini-              review. Yeast 8:423â€“ 488. http://dx.doi.org/10.1002/yea.320080602.
    mal enzyme  Nucleic Acids Res. 41:6332â€“ 6346. http://dx.doi.org       36.   Parthier C, GÃ¶rlich S, Jaenecke F, Breithaupt C, BrÃ¤uer U, Fandrich U,
    /10.1093/nar/gkt322.                                                               Clausnitzer D, Wehmeier UF, BÃ¶ttcher C, Scheel D, Stubbs MT. 2012.
18. Sibler AP, Dirheimer G, Martin RP. 1986. Codon reading patterns                 O-carbamoyltransferase TobZ catalyzes ancient enzymatic reac-
    Saccharomyces cerevisiae mitochondria based sequences mitochon-              tion. Angew. Chem. Int. Ed. Engl. 51:4046 â€“ 4052. http://dx.doi.org/10
    drial tRNAs. FEBS Lett. 194:131â€“138. http://dx.doi.org/10.1016/0014                .1002/anie.201108896.
    -5793(86)80064-3.                                                            37.   Yu H, Braun P, Yildirim MA, Lemmens  Venkatesan K, Sahalie J,
19. Oberto J, Breuil N, Hecker  Farina F, Brochier-Armanet C, Culetto E,             Hirozane-Kishikawa T, Gebreab F, Li N, Simonis N, Hao T, Rual J